NFATC1 and Alzheimer disease: For instance, N-methyl-D-aspartate receptors open channel blocker memantine is used to treat AD, which correlates with a reduction in T-cell receptor (TCR)-induced Ca(2+) mobilization and nuclear localization of NFATC1 (89).